You just read:

In Hospital-Acquired Pneumonia, Thought Leaders' Opinions and Clinical Data Indicate that Eravacycline Offers Efficacy and Delivery Advantages Over Currently Marketed Therapies

News provided by

Decision Resources

Apr 24, 2013, 09:00 ET